1. Home
  2. HBCP vs ESPR Comparison

HBCP vs ESPR Comparison

Compare HBCP & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Bancorp Inc.

HBCP

Home Bancorp Inc.

HOLD

Current Price

$57.96

Market Cap

434.2M

Sector

Finance

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.85

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBCP
ESPR
Founded
1908
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
434.2M
898.5M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
HBCP
ESPR
Price
$57.96
$3.85
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$63.50
$6.67
AVG Volume (30 Days)
22.9K
4.8M
Earning Date
01-26-2026
11-06-2025
Dividend Yield
2.13%
N/A
EPS Growth
24.56
N/A
EPS
5.62
N/A
Revenue
$145,087,000.00
$303,802,000.00
Revenue This Year
$2.60
$26.11
Revenue Next Year
$3.27
N/A
P/E Ratio
$10.38
N/A
Revenue Growth
11.42
2.83
52 Week Low
$39.59
$0.69
52 Week High
$62.15
$4.13

Technical Indicators

Market Signals
Indicator
HBCP
ESPR
Relative Strength Index (RSI) 48.31 54.66
Support Level $57.38 $3.63
Resistance Level $59.37 $3.89
Average True Range (ATR) 1.11 0.19
MACD -0.42 -0.04
Stochastic Oscillator 20.90 43.00

Price Performance

Historical Comparison
HBCP
ESPR

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: